An official website of the United States government
HDRP Newsletter, August 2018
Message from the HDRP Associate Director
Welcome to the revised HDRP newsletter! This newsletter has been redesigned based on feedback we received back in February when we fielded a brief survey to evaluate our communication activities. We hope that you find that we have been responsive to your requests for more content on funding announcements, upcoming events, and research data and resources. Our plan is to create shorter newsletters that are issued more frequently throughout the year so that you receive pertinent information in a timelier fashion. We hope that the revamped format will better suit your needs and the needs of our broader research community.
We welcome your feedback on how we can continue to improve upon this communication vehicle. Thank you for your efforts to advance innovative research to improve the delivery of cancer-related care.
Paul Jacobsen, PhD
Funding
*NEW* Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional), PAR-18-869
Contact: Scott Rogers
Next Submission Date: November 7, 2018
Expiration Date: March 9, 2021
An informational webinar about this funding opportunity will be held on September 12 at 10:00AM ET.*NEW* Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required), RFA-CA-19-017
Contact: Erica Breslau
Application Due Date: January 9, 2019
Watch your email or check our website for additional information about an upcoming webinar.Digital Healthcare Platform to Reduce Financial Hardship for Cancer Patients, Topic #384
[Small Business Innovation Research (SBIR) Contract Solicitation]Expiration Date: October 22, 2018
Leveraging Connected Health Technologies to Address and Improve Health Outcomes of Long-Term Cancer Survivors, Topic #385
[Small Business Innovation Research (SBIR) Contract Solicitation]Expiration Date: October 22, 2018
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required), RFA-CA-18-026
Contact: Shobha Srinivasan, Ph.D.
Application Due Date: September 19, 2018
An informational webinar about this funding opportunity was held on July 10, 2018 and is archived here.
For more information about funding, please visit our website
Policy Updates
NIH/AHRQ Application Submission/Resubmission Policy
Updated policy notice that provides clarity on policies pertaining to allowable submissions and resubmissions.
Upcoming Events and Presentations
Developing a Framework for Measuring Quality of Cancer Survivorship Care: NCI/AcademyHealth Healthcare Delivery Research Visiting Scholar Webinar
August 28, 2018 at 3:00 PM ET
This webinar will feature the work of 2017-2018 NCI/AcademyHealth Healthcare Delivery Research Visiting Scholar, Larissa Nekhlyudov, M.D., M.P.H. Registration (free) is required.Modular R01s in Cancer Control and Population: Informational Webinar
September 12, 2018 at 10:00 AM ET [Register here
]
This webinar will provide an overview of the new funding opportunity PAR-18-869 followed by a Q&A session. Dr. Ann Geiger, HDRP Deputy Associate Director, will present on behalf of HDRP.Meet the Experts Networking Luncheon at ASCO Quality Care Symposium
September 29, 2018, 11:30AM - 12:30PM
Phoenix, AZ
Staff members from across HDRP will be present, including Dr. Paul Jacobsen, HDRP Associate DirectorTranslation and Linguistic Validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in 10 Languages: ISOQOL Presentation
October 25, 2018, 4:05PM
Dublin, Ireland
Presenter: Dr. Sandra Mitchell, Program Director, Outcomes Research BranchPROMIS and Person-centered Health Measurement: Updates from the NIH: PROMIS Health Organization Presentation
October 29, 2019, 9:00AM
Dublin, Ireland
Presenter: Dr. Ashley Smith, Chief, Outcomes Research Branch11th Annual Conference on the Science of Dissemination and Implementation in Health
December 3-5, 2018
Washington, DC
Data and Resources
PRO-CTCAE New Language Translations
The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) is a patient-reported outcome measure developed to evaluate symptomatic toxicity in patients on cancer clinical trials. It was designed to be used as a companion to the Common Terminology Criteria for Adverse Events (CTCAE), the standard lexicon for adverse event reporting in cancer trials. PRO-CTCAE is now available in 16 languages. For a full list of languages, visit our website.
Video: Cancer Care Delivery Research within the NCI Community Oncology Research Program
HDRP produced a brief video to describe Cancer Care Delivery Research within the NCI Community Oncology Research Program. The video features Deputy Associate Director, Dr. Ann Geiger, and is available for viewing on our website.
Career and Training Opportunities
Medical Officer, Healthcare Assessment Research Branch
The position has been filled.